These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10694575)

  • 1. Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice.
    Belz GT; Stevenson PG; Castrucci MR; Altman JD; Doherty PC
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2725-30. PubMed ID: 10694575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope.
    Stevenson PG; Belz GT; Castrucci MR; Altman JD; Doherty PC
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9281-6. PubMed ID: 10430934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced functional capacity of CD8+ T cells expanded by post-exposure vaccination of gamma-herpesvirus-infected CD4-deficient mice.
    Liu H; Andreansky S; Diaz G; Hogg T; Doherty PC
    J Immunol; 2002 Apr; 168(7):3477-83. PubMed ID: 11907108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-specific CD8(+) T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice.
    Stevenson PG; Belz GT; Altman JD; Doherty PC
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15565-70. PubMed ID: 9861009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perforin and Fas in murine gammaherpesvirus-specific CD8(+) T cell control and morbidity.
    Topham DJ; Cardin RC; Christensen JP; Brooks JW; Belz GT; Doherty PC
    J Gen Virol; 2001 Aug; 82(Pt 8):1971-1981. PubMed ID: 11458005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the host response to a gamma-herpesvirus.
    Doherty PC; Christensen JP; Belz GT; Stevenson PG; Sangster MY
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):581-93. PubMed ID: 11313013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of murine gamma-herpesvirus infection.
    Nash AA; Dutia BM; Stewart JP; Davison AJ
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of the CD8+ T-cell response to readily eliminated and persistent viruses.
    Doherty PC; Riberdy JM; Belz GT
    Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1093-101. PubMed ID: 11186311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An optimized CD8+ T-cell response controls productive and latent gammaherpesvirus infection.
    Braaten DC; Sparks-Thissen RL; Kreher S; Speck SH; Virgin HW
    J Virol; 2005 Feb; 79(4):2573-83. PubMed ID: 15681457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The route of immunization with adenoviral vaccine influences the recruitment of cytotoxic T lymphocytes in the lung that provide potent protection from influenza A virus.
    Suda T; Kawano M; Nogi Y; Ohno N; Akatsuka T; Matsui M
    Antiviral Res; 2011 Sep; 91(3):252-8. PubMed ID: 21722671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential tumor necrosis factor receptor 2-mediated editing of virus-specific CD8+ effector T cells.
    Turner SJ; La Gruta NL; Stambas J; Diaz G; Doherty PC
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3545-50. PubMed ID: 14993609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection.
    Sparks-Thissen RL; Braaten DC; Kreher S; Speck SH; Virgin HW
    J Virol; 2004 Jul; 78(13):6827-35. PubMed ID: 15194758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection.
    Samreen B; Tao S; Tischer K; Adler H; Drexler I
    Front Immunol; 2019; 10():2984. PubMed ID: 31921215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The limits of protection by "memory" T cells in Ig-/- mice persistently infected with a gamma-herpesvirus.
    Andreansky S; Liu H; Adler H; Koszinowski UH; Efstathiou S; Doherty PC
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2017-22. PubMed ID: 14764895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection.
    Hussell T; Georgiou A; Sparer TE; Matthews S; Pala P; Openshaw PJ
    J Immunol; 1998 Dec; 161(11):6215-22. PubMed ID: 9834108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice.
    Liu L; Usherwood EJ; Blackman MA; Woodland DL
    J Virol; 1999 Dec; 73(12):9849-57. PubMed ID: 10559297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for CD4+ T cells in V beta 4+CD8+ T cell activation associated with latent murine gammaherpesvirus infection.
    Flaño E; Woodland DL; Blackman MA
    J Immunol; 1999 Sep; 163(6):3403-8. PubMed ID: 10477611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive CD8+ T cells arise in the absence of CD4 help and compromise control of persistent virus.
    Molloy MJ; Zhang W; Usherwood EJ
    J Immunol; 2011 Jun; 186(11):6218-26. PubMed ID: 21531895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
    Bristol JA; Schlom J; Abrams SI
    Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
    Holst PJ; Christensen JP; Thomsen AR
    J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.